{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:41:45Z","timestamp":1792827705110,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011354","name":"University of Michigan Rogel Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016939","name":"Myriad Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008456","name":"A. Alfred Taubman Medical Research Institute","doi-asserted-by":"publisher","award":["2P50CA186786-06"],"award-info":[{"award-number":["2P50CA186786-06"]}],"id":[{"id":"10.13039\/100008456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.urology.2021.05.078","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:38:49Z","timestamp":1626478729000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Initial Findings from a High Genetic Risk Prostate Cancer Clinic"],"prefix":"10.1016","volume":"156","author":[{"given":"Michael S.","family":"Sessine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumsoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simpa S.","family":"Salami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kasputis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Solorzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy A.","family":"Vince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Borza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Stoffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Cobain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia D.","family":"Merajver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle F.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara J.","family":"Milliron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leander","family":"van Neste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Mondul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2021.05.078_bib0001","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.eururo.2014.01.003","article-title":"Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study","volume":"66","author":"Bancroft","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.05.078_bib0002","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.eururo.2019.08.019","article-title":"Interim Results from the IMPACT Study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers","volume":"76","author":"Page","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.05.078_bib0003","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/bjc.2011.383","article-title":"BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients","volume":"105","author":"Kote-Jarai","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2021.05.078_bib0004","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/bjc.2012.146","article-title":"Germline BRCA1 mutations increase prostate cancer risk","volume":"106","author":"Leongamornlert","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2021.05.078_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00006254-200301000-00016","article-title":"Cancer Incidence in BRCA1 Mutation Carriers","volume":"58","author":"Thompson","year":"2003","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.urology.2021.05.078_bib0006","first-page":"1","article-title":"NCCN Prostate cancer early detection panel","volume":"2","year":"2021","journal-title":"Clin Pract Guidel Oncol"},{"key":"10.1016\/j.urology.2021.05.078_bib0007","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2018.0271","article-title":"Malignant abnormalities in male BRCA mutation carriers","volume":"4","author":"Mano","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2021.05.078_bib0008","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2021.05.078_bib0009","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2021.05.078_bib0010","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/djm130","article-title":"Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the prostate cancer prevention trial","volume":"99","author":"Cohen","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2021.05.078_bib0011","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the selenium and vitamin e cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2021.05.078_bib0012","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pros.22573","article-title":"Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer","volume":"73","author":"Algotar","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2021.05.078_bib0013","first-page":"1799","article-title":"Smoking and aggressive prostate cancer: a review of the epidemiologic evidence","volume":"20","author":"Zu","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2021.05.078_bib0014","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2105\/AJPH.2008.150508","article-title":"Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies","volume":"4","author":"Huncharek","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.urology.2021.05.078_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-642-45195-9_3","article-title":"Lifestyle and dietary factors in prostate cancer prevention","volume":"202","author":"Discacciati","year":"2014","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.urology.2021.05.078_bib0016","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.eururo.2011.07.007","article-title":"Does physical activity reduce the risk of prostate cancer? asystematic review and meta-analysis","volume":"60","author":"Liu","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.05.078_bib0017","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2021.05.078_bib0018","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1634\/theoncologist.2015-0336","article-title":"The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer","volume":"21","author":"Castro","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2021.05.078_bib0019","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2017.10.036","article-title":"genomic markers in prostate cancer decision making","volume":"73","author":"Cucchiara","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.05.078_bib0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/JU.0000000000000293","article-title":"Multicenter optimization and validation of a 2-gene mrna urine test for detection of clinically significant prostate cancer before initial prostate biopsy","volume":"202","author":"Haese","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.05.078_bib0021","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.04.012","article-title":"Detection of high-grade prostate cancer using a urinary molecular biomarker\u2013based risk score","volume":"70","author":"Van Neste","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.05.078_bib0022","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic,","volume":"18","author":"Daly","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.urology.2021.05.078_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/294575","article-title":"CHEK2\u2217 1100delC mutation and risk of prostate cancer","volume":"2014","author":"Hale","year":"2014","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.urology.2021.05.078_bib0024","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1158\/1055-9965.EPI-09-0058","article-title":"Germ-line mutations in mismatch repair genes associated with prostate cancer","volume":"18","author":"Grindedal","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2021.05.078_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S16747","article-title":"Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates","volume":"4","author":"Leitzmann","year":"2012","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.urology.2021.05.078_bib0026","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7314\/APJCP.2013.14.9.4965","article-title":"Alcohol consumption and risk of cancer: a systematic literature review","volume":"14","author":"de Menezes","year":"2013","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10.1016\/j.urology.2021.05.078_bib0027","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-07-2888","article-title":"Alcohol consumption and the risk for prostate cancer in the european prospective investigation into cancer and nutrition","volume":"17","author":"Rohrmann","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2021.05.078_bib0028","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","article-title":"Assessing women at high risk of breast cancer: a review of risk assessment models","volume":"102","author":"Amir","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2021.05.078_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gore.2019.01.010","article-title":"Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast\/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers","volume":"28","author":"Stewart","year":"2019","journal-title":"Gynecol Oncol reports"},{"key":"10.1016\/j.urology.2021.05.078_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/tbj.13007","article-title":"Impact of preoperative BRCA1\/2 testing on surgical decision making in patients with newly diagnosed breast cancer","volume":"24","author":"Yadav","year":"2018","journal-title":"Breast J"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521006476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521006476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:51:50Z","timestamp":1758768710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429521006476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"alternative-id":["S0090429521006476"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.05.078","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial Findings from a High Genetic Risk Prostate Cancer Clinic","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.05.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}